Immediate Impact
1 from Science/Nature 22 standout
Citing Papers
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
2025 Standout
Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model
2024 StandoutScience
Works of Christopher M. Goins being referenced
Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CLpro)
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Christopher M. Goins | 89 | 110 | 120 | 14 | 298 | |
| Mutaib M. Mashraqi | 61 | 170 | 75 | 36 | 329 | |
| Moustafa M. Saleh | 37 | 137 | 67 | 16 | 271 | |
| Valeria Francesconi | 35 | 80 | 126 | 17 | 294 | |
| Saleh Alshamrani | 72 | 110 | 38 | 30 | 327 | |
| Amar Ajmal | 24 | 134 | 94 | 24 | 284 | |
| Ahmed M. Said | 35 | 111 | 162 | 27 | 316 | |
| Yuan Ju | 32 | 161 | 66 | 26 | 304 | |
| Manish Sharma | 77 | 71 | 170 | 14 | 312 | |
| Abdul Rashid Issahaku | 17 | 144 | 58 | 32 | 273 | |
| Philipe Oliveira Fernandes | 26 | 99 | 149 | 13 | 290 |
All Works
Login with ORCID to disown or claim papers
Loading papers...